Matches in Wikidata for { <http://www.wikidata.org/entity/Q63334503> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q63334503 description "clinical trial" @default.
- Q63334503 description "ensayu clínicu" @default.
- Q63334503 description "klinisch onderzoek" @default.
- Q63334503 description "клінічне випробування" @default.
- Q63334503 name "Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia" @default.
- Q63334503 type Item @default.
- Q63334503 label "Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia" @default.
- Q63334503 prefLabel "Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia" @default.
- Q63334503 P1050 Q63334503-1BA5598F-5739-4CC6-ADD3-E57C09ED7EAC @default.
- Q63334503 P1132 Q63334503-79A87896-C1FE-465F-AEE0-5C044A9975B2 @default.
- Q63334503 P1476 Q63334503-288351D7-7AF8-4455-B785-76839308A45B @default.
- Q63334503 P17 Q63334503-398B5568-7348-48F1-869E-E7F838C12458 @default.
- Q63334503 P17 Q63334503-83F283C2-E7BF-40CF-BB28-9A13DCC508DF @default.
- Q63334503 P1813 Q63334503-430B81F6-9BDD-4507-8A4D-4E0E9151DD57 @default.
- Q63334503 P2899 Q63334503-07AF5384-D88D-4615-B30B-560E2E8F33A4 @default.
- Q63334503 P3098 Q63334503-DD15F5E6-5A12-488F-82EA-50C14E699F48 @default.
- Q63334503 P31 Q63334503-E30F0413-92BB-4DB3-B2AA-2CAC634239D9 @default.
- Q63334503 P4135 Q63334503-D2D2C9B2-C0A7-41BB-BD0D-C26E016CFB2D @default.
- Q63334503 P4844 Q63334503-65AE20E8-F3E8-4977-8435-CFE7BE0BD9D1 @default.
- Q63334503 P580 Q63334503-74464780-FE7C-4592-B5BA-211FE6684B15 @default.
- Q63334503 P582 Q63334503-3154A25F-71C2-440A-87F4-2E1787C4881B @default.
- Q63334503 P6099 Q63334503-5A610EB9-ADC9-4942-9E75-C4B60797BA41 @default.
- Q63334503 P6099 Q63334503-9C2F0496-FEF3-42EC-9E74-5FAF40A78F2E @default.
- Q63334503 P8363 Q63334503-E004D0AA-37D9-48FB-A3F8-9C6A6E35FE4E @default.
- Q63334503 P1050 Q41112 @default.
- Q63334503 P1132 "+269" @default.
- Q63334503 P1476 "A Randomized, Double-Blind, Active-Controlled,Phase 2/3 Study to Determine the Short-Term (6-Week) and Long-Term (6 Month) Cognitive and Anti-Psychotic Efficacy, Safety and Tolerability of CYP-1020 Compared to Risperidone in Patients With Schizophrenia" @default.
- Q63334503 P17 Q218 @default.
- Q63334503 P17 Q668 @default.
- Q63334503 P1813 "CLARITY" @default.
- Q63334503 P2899 "+18" @default.
- Q63334503 P3098 "NCT01363349" @default.
- Q63334503 P31 Q30612 @default.
- Q63334503 P4135 "+50" @default.
- Q63334503 P4844 Q412443 @default.
- Q63334503 P580 "2011-05-01T00:00:00Z" @default.
- Q63334503 P582 "2013-03-01T00:00:00Z" @default.
- Q63334503 P6099 Q42824440 @default.
- Q63334503 P6099 Q42824827 @default.
- Q63334503 P8363 Q78089383 @default.